What is the recommended dosage of Deviry (Norethindrone) tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dosage of Deviry (Norethindrone) tablet is not explicitly stated in the provided evidence, but based on the information about progestin only pills (POPs) containing norethindrone, it can be inferred that the dosage is likely to be a standard dose used in such formulations, which is typically 0.35 mg taken orally once a day 1.

Key Considerations

  • The provided evidence discusses the history and development of oral contraceptive pills (OCPs), including the use of norethindrone as a first-generation progestin 1.
  • It mentions that progestin only pills (POPs) containing norethindrone are available for contraceptive purposes but are associated with irregular bleeding and need to be taken at the same time each day 1.
  • The evidence highlights the evolution of OCPs to reduce adverse effects, including the reduction of estrogen doses and the development of newer progestins with more favorable side effect profiles 1.

Clinical Implications

  • When prescribing Deviry (Norethindrone) tablets, it is essential to consider the patient's medical history, including any history of thromboembolic events, hypertension, or other conditions that may be affected by the use of progestin-only contraceptives 1.
  • Patients should be advised to take the tablet at the same time each day to maintain consistent hormone levels and maximize contraceptive effectiveness.
  • As with any hormonal contraceptive, regular follow-up appointments are necessary to monitor for any adverse effects and to address any concerns or questions the patient may have.

From the Research

Dosage Information

  • The recommended dosage of Deviry (Norethindrone) tablet is not explicitly stated in the provided studies 2, 3, 4, 5, 6.
  • However, the studies discuss the use of norethindrone in various contraceptive and menstrual bleeding treatments, but do not provide specific dosage information for Deviry.

Related Studies

  • A study on cyclical progestogens for heavy menstrual bleeding compared the effectiveness of different types and regimens of oral progestogens, including norethisterone, but did not provide dosage information for Deviry 3.
  • Another study on injectable contraception mentioned norethindrone enanthate as a widely used injectable outside the United States, but did not discuss Deviry specifically 4.
  • Studies on depot medroxyprogesterone acetate (DMPA) and levonorgestrel-releasing intrauterine system discussed treatment of heavy menstrual bleeding, but did not provide information on Deviry dosage 5, 6.

Conclusion Not Available

There are no research papers to assist in answering this question regarding the recommended dosage of Deviry (Norethindrone) tablet.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

3-month contraceptive injection approved.

FDA medical bulletin : important information for health professionals from the U.S. Food & Drug Administration, 1993

Research

Cyclical progestogens for heavy menstrual bleeding.

The Cochrane database of systematic reviews, 2019

Research

Injectable contraception.

Clinical obstetrics and gynecology, 2007

Research

Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: a randomized clinical trial.

Medical science monitor : international medical journal of experimental and clinical research, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.